Creode
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
Creating therapeutic abundance
On limiting reagents in the medicine production function
Jul 7
•
Jacob Kimmel
73
9
August 2024
Predictive biology
An emergent epistemology
Aug 30, 2024
•
Jacob Kimmel
106
5
January 2024
2023 Best Books
Designing therapies, building companies, developing agency
Jan 14, 2024
•
Jacob Kimmel
3
December 2023
Techbio is a speciation event
High-entropy neologisms & the evolution of life sciences firms
Dec 29, 2023
•
Jacob Kimmel
15
February 2023
2022 Best Books
The Power Law — Sebastian Mallaby
Feb 6, 2023
•
Jacob Kimmel
August 2022
Designing reprogramming therapies
This is a cross-post from the NewLimit Blog
Aug 12, 2022
•
Jacob Kimmel
1
December 2021
2021 Best Books
In 2020, I learned the most from reading historical accounts of scientific progress and funding, particularly in my field of biotechnology.
Dec 30, 2021
•
Jacob Kimmel
Learning representations of life
I’m frequently asked how I think machine learning tools will change our approach to molecular and cell biology.
Dec 6, 2021
•
Jacob Kimmel
3
May 2021
Rejuvenation By Reprogramming
Paper: https://doi.org/10.1016/j.cels.2022.05.002
May 26, 2021
•
Jacob Kimmel
1
December 2020
2020 Best Books
As a kid, I used to dream about a room filled with books where time was dilated.
Dec 19, 2020
•
Jacob Kimmel
October 2020
Her-2 – The Making of Herceptin
How are new medicine’s invented?
Oct 3, 2020
•
Jacob Kimmel
2
June 2020
Inventing the NIH
This post began as a book review of Inventing the NIH by Victoria Angela Harden, but grew out a bit from there.
Jun 21, 2020
•
Jacob Kimmel
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts